Viewing Study NCT05805956


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2025-12-25 @ 9:24 PM
Study NCT ID: NCT05805956
Status: UNKNOWN
Last Update Posted: 2023-04-10
First Post: 2023-03-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module